 The Australian Therapeutic Goods Administration has approved ElectroCore Incs NASDAQ: ECOR gammaCore Sapphire family of products, including a non-invasive vagus nerve stimulator nVNS for primary headache disorders. Concurrently, the company has entered into an agreement with Medistar2 PTY Limited, whereby Medistar will serve as the exclusive distributor of the gammaCore Sapphire nVNS in Australia. 